← 483 OBSERVATION EXPLORER

FDA 483 OBSERVATION · #400 OF 1,000 MOST-CITED

Quality control - supplier qualification

FDA cited this observation 49 times across 47 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Foods49
BY FISCAL YEAR
FY20262
FY20254
FY20247
FY20235
FY20228
FY20211
FY20202
FY201912
FY20183
FY20175

How FDA worded it — real examples

Your quality control personnel did not review and approve the documentation setting forth the basis for qualification of suppliers.

PYR Less Group, LLC · Amarillo, Texas · Foods · 2026-01-23

Your quality control personnel did not review and approve the documentation setting forth the basis for qualification of suppliers.

InScience Solutions LLC · Allen, Texas · Foods · 2025-10-07

Your quality control personnel did not review and approve the documentation setting forth the basis for qualification of suppliers.

GAYATRI AYUPHARMA PVT LTD · Chandial · Foods · 2025-06-24

Your quality control personnel did not review and approve the documentation setting forth the basis for qualification of suppliers.

Western Innovations, Inc. · Denver, Colorado · Foods · 2025-04-30

Your quality control personnel did not review and approve the documentation setting forth the basis for qualification of suppliers.

Far East Summit LLC · Dexter, Oregon · Foods · 2025-04-18

Your quality control personnel did not review and approve the documentation setting forth the basis for qualification of suppliers.

FALCON SYSTEM OF AYURVEDIC PRODUCTS · Belgaum · Foods · 2024-11-13

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Pharmaceutical quality systemFood industry

Examples are a representative sample of FDA's published inspection observations. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →